Media

On April 14, 2025, YRPG’s First Health Culture Festival officially opened at the Health Plaza. During the opening ceremony, EFQM Global Award assessors from Germany, the United Kingdom, Portugal, Spain, and China practiced Baduanjin, a traditional Chinese health exercise, experiencing the unique charm of Chinese wellness culture firsthand.At the Health Forum, distinguished guests from academia and industry gathered to discuss key topics including industrial strategy, the inheritance of TCMs, hea

On April 1, 2025, Ms. Sabrine Tabboubi, Head of Health Affairs at the UAE Embassy in China and former Health Attaché Secretary at the Saudi Embassy in China, led a delegation to visit Yangtze River Pharmaceutical Group.During the visit, the delegation toured the Longfengtang factory, the Group’s headquarters, and the Longfengtang Traditional Chinese Medicine Exhibition Hall. The state-of-the-art production facilities, rigorous quality management system, and comprehensive traditional Chinese medi

YRPG earned three gold awards at the 49th International Convention on Quality Control Circles (ICQCC) held in mid-November 2024, raising its total number of international quality awards to 31. The group contributed to drafting the Quality Risk Management Requirements and Implementation Guidelines for Pharmaceutical Manufacturing, which came into effect in June 2024, serving as a reference for quality management across the pharmaceutical industry.Strengthening our commitment to collaborative supp

On February 24, 2025, YRPG made its debut at the 61st Salon International de l'Agriculture, where it showcased a range of innovative health and agricultural products. Among the featured offerings were Astragalus Coffee, Blue Honeysuckle Lozenges, Blue Honeysuckle Powder, and Selenium-Enriched Rice, which attracted significant interest, particularly among younger attendees. Through this platform, YRPG introduced more people to high-quality Chinese health products and met the diverse needs of Fren

On November 28, YRPG released its first “Environmental, Social and Governance (ESG) Report” at the 2nd Biopharmaceutical Supply Chain Conference. This marks the Group’s first external disclosure of its annual environmental protection, social responsibility, and governance achievements. The report covers multiple aspects such as quality management, green and low-carbon transformation, and social welfare, systematically reviewing and summarizing YRPG’s ESG practices and accomplishments for 2023.

On November 21, 2024, a seminar on the Phase III clinical trial protocol of YZJ-4729 Tartrate Injection for postoperative analgesia following abdominal surgery was held at Meixi Lake Luxury Collection Hotel in Changsha. Hosted by the Drug Research Institute of YRPG, the seminar invited Professor Ouyang Wen and Professor Wang Saiying from the Third Xiangya Hospital of Central South University, as well as experts from various anesthesia and clinical pharmaceutical research institutions across the

On October 16, 2024, the 45th National Conference on Quality Control (QC) Circle Achievements in the Pharmaceutical Industry concluded in Changsha, Hunan. YRPG won first prizes for 106 QC team achievements, marking its twentieth consecutive year of winning the most first prizes in team achievements in this conference. The conference also awarded Xu Haoyu, the Party Secretary, Chairman, and President of the Group, the title "Outstanding Leader." YRPG was awarded the title of “Excellent Enterprise

On August 10th, at the 17th Health Industry (International) Ecology Conference - 2024 China Pharmaceutical Ecology Organization（CPEO）, YRPG launched the Longfengtang Astragalus Brand and officially initiated 100,000 urban gas replenishment stations, empowering retail pharmacy partners to find new growth opportunities in health marketing.